# Intranasal Insulin for Prevention of Type 1 Diabetes

> **NCT00223613** · PHASE3 · UNKNOWN · sponsor: **University of Turku** · enrollment: 240 (—)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** daily intranasal administration of insulin

## Key facts

- **NCT ID:** NCT00223613
- **Lead sponsor:** University of Turku
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1997-08
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 240 (—)
- **Last updated:** 2006-09-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00223613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00223613, "Intranasal Insulin for Prevention of Type 1 Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00223613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*